CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,385,038 | +188.3% | 329,771 | +312.5% | 0.00% | – |
| Q4 2022 | $480,415 | -78.4% | 79,936 | -79.1% | 0.00% | -100.0% |
| Q3 2022 | $2,227,000 | +99.2% | 382,686 | +104.2% | 0.00% | – |
| Q2 2022 | $1,118,000 | -31.6% | 187,403 | -46.5% | 0.00% | – |
| Q1 2022 | $1,635,000 | +514.7% | 350,283 | +226.0% | 0.00% | – |
| Q4 2021 | $266,000 | +421.6% | 107,449 | +520.4% | 0.00% | – |
| Q3 2021 | $51,000 | +54.5% | 17,319 | +11.6% | 0.00% | – |
| Q3 2020 | $33,000 | -72.3% | 15,519 | -88.8% | 0.00% | – |
| Q2 2019 | $119,000 | +1222.2% | 138,330 | +998.5% | 0.00% | – |
| Q4 2018 | $9,000 | -98.1% | 12,593 | -92.9% | 0.00% | -100.0% |
| Q4 2017 | $472,000 | +102.6% | 176,171 | +218.0% | 0.00% | 0.0% |
| Q1 2017 | $233,000 | – | 55,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |